← Leaderboards
Edward M Behrens
University Of Pennsylvania
$6,055,208
Attributed
$9,603,977
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,603,977 · 6
By mechanism
R01$5,096,661 · 2
T32$3,837,716 · 3
K08$669,600 · 1
Top collaborators
- Peter A Merkel9 shared
- Taku Kambayashi7 shared
- Warren S Pear2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Amit Maity$4,832,230
- Stephen G Emerson$28,932,839
- Constantinos Koumenis$17,144,115
- Melpo Christofidou-Solomidou$5,805,617
- Eric J Bernhard$2,381,828
Others in their field
Top investigators on “Rheumatism”
- Betty Diamond · Feinstein Institute For Medical Research$17,429,471
- Judith A James · Oklahoma Medical Research Foundation$13,075,216
- Daniel Hal Solomon · Brigham And Women'S Hospital$11,952,084
- Antony Rosen · Johns Hopkins University$11,457,651
- Livia A Casciola-Rosen · Johns Hopkins University$11,053,624
- Michael B Brenner · Brigham And Women'S Hospital$10,290,183
Research focus
RheumatismAnimal ModelCell PhysiologyCytokineResponseMediatingLeadSignal TransductionT-LymphocyteCellsTraining ProgramsInvestigationIn VivoInterferon Type IiInflammationInfectionInflammatoryMouse ModelAntigen PresentationImmune ResponseDendritic CellsFamilial Hemophagocytic LymphohistiocytosisAntigen-Presenting CellsEvent
Grant awards (26)
Physician Scientist Training Program in Immune Dysregulation$364,359
T32 · FY2025 · AI
Training Program/Rheumatic Diseases$343,814
T32 · FY2025 · AR
Training Program/Rheumatic Diseases$399,277
T32 · FY2024 · AR
Physician Scientist Training Program in Immune Dysregulation$373,359
T32 · FY2024 · AI
Training Program/Rheumatic Diseases$346,766
T32 · FY2023 · AR
Training Program/Rheumatic Diseases$350,055
T32 · FY2022 · AR
Training Program/Rheumatic Diseases$380,125
T32 · FY2021 · AR
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes$586,684
R01 · FY2020 · AI · contact PI
Training Program/Rheumatic Diseases$374,707
T32 · FY2020 · AR
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes$590,951
R01 · FY2019 · AI · contact PI
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes$594,670
R01 · FY2018 · AI · contact PI
Training Program/Rheumatic Diseases$200,295
T32 · FY2018 · AR
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes$598,527
R01 · FY2017 · AI · contact PI
The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome$415,967
R01 · FY2017 · HL · contact PI
Training Program/Rheumatic Diseases$343,253
T32 · FY2017 · AR
IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes$643,084
R01 · FY2016 · AI · contact PI
The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome$416,049
R01 · FY2016 · HL · contact PI
Training Program/Rheumatic Diseases$361,706
T32 · FY2016 · AR
The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome$413,877
R01 · FY2015 · HL · contact PI
The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome$414,256
R01 · FY2014 · HL · contact PI
The Opposing Roles of IL-10 and IFN-gamma in Macrophage Activation Syndrome$422,596
R01 · FY2013 · HL · contact PI
Mechanisms and Therapeutic Use of CR3 Signaling in Modulating Autoimmunity$133,920
K08 · FY2013 · AI · contact PI
Mechanisms and Therapeutic Use of CR3 Signaling in Modulating Autoimmunity$133,920
K08 · FY2012 · AI · contact PI
Mechanisms and Therapeutic Use of CR3 Signaling in Modulating Autoimmunity$133,920
K08 · FY2011 · AI · contact PI
Mechanisms and Therapeutic Use of CR3 Signaling in Modulating Autoimmunity$133,920
K08 · FY2010 · AI · contact PI
Mechanisms and Therapeutic Use of CR3 Signaling in Modulating Autoimmunity$133,920
K08 · FY2009 · AI · contact PI